Dawnrays Pharmaceutical (Holdings) Limited

Press Releases       

2010-September-13	Dawnrays Pharmaceutical (Holdings) Limited Entecavir Dispersible Tablets and Entecavir Bulk Medicine - A New Generic Drug for the Treatment of Chronic Hepatitis B Have Received Approval from the State Food and Drug Administration (in PDF)
2010-August-27	Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results For The Six Months Ended 30 June 2010: Net Profit After Tax Jumped 71.3% to RMB 87.50 Million, An Interim Dividend of HK$ 0.02 per Share was Declared (in PDF)
2010-March-30	Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2009: Net Profit after Tax Jumped 15.9% to RMB 118.34 Million, a Final Dividend of HK$ 0.05 per Share was Declared (in PDF)
2012	2012 Press Releases
2011	2011 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases